Approaching The Response To Audit Observations

Size: px
Start display at page:

Download "Approaching The Response To Audit Observations"

Transcription

1 Approaching The Response To Audit Observations By Troy Fugate Understanding your systems and taking responsible and appropriate actions are at the core of beneficial audit responses. Systemically applying response strategies yield the greatest rewards. INTRODUCTION One of the first things consistently drilled into our collective memory in the quality world is the statement that we should always be prepared for an audit. It is a number one priority prevailing over our activities as a quality unit. The reason is simple; always being prepared prevents, or at least minimizes, the peaks and valleys of audit preparation. This is demonstrated by the graphic of an audit cycle shown in Figure 1. Since experience is gained not only at the front end, during audit preparation, but also at the back end, during audit response, it is evident that if Always be Prepared is a number one priority, then a number two priority is Respond Systemically to any observation. If done properly, systemic resolution to issues should eliminate the peaks and valleys syndrome outlined in Figure 1. Understanding the Observations It is essential that the observations be understood and evaluated in the context in which they were given. Personnel involved with the audit should have input into the reasoning behind the issue. Hopefully, the auditor will provide feedback either when the observation was made or on a daily basis. This is an opportunity to understand the points being made. Typically, the last prospect for obtaining feedback directly from an auditor is during the close-out meeting. The close-out meeting is a review of the observations made by the auditor. For the U.S. FDA, when a Form 483 is issued, the firm will receive it during this close-out. For the Medicines and Healthcare Products Regulatory Agency (MHRA), the firm will receive a verbal list of observations. The written list will follow in about two weeks. For internal, corporate, or external auditors, there is usually a verbal close-out meeting followed shortly thereafter with a formal report. During the close-out meeting (especially during formal or governmental audits), it is important to have the appropriate personnel in attendance. Attendees usually represent Quality Assurance, Regulatory Affairs, Operations, and Senior Management. It is important to keep the number of personnel in attendance to a reasonable level. Too many people and the auditor may become uncomfortable. Too few and it may seem that you are not taking the audit seriously. Decide in advance how you are going to approach the close-out meeting. Will you question every observation and attempt to get them removed - analogous to a Scorched Earth Policy? Will you accept every observation even if there are errors present? Who will comment on the observations - everyone? Will people debate or disagree with valid observations? A good approach is typically one that abides by the following outline: Special Edition: Conducting Audits 33

2 Figure 1 Audit Cycle Audit complete company at a high state of compliance Audit Announced Cycle Repeats! Now that the audit is over, we can get back to some real work Overtime, extra help, replace items, conduct training RUSH, RUSH Lower Level of Compliance High Level of Compliance The head of Quality is the one who hosts the audit and will be the firm s representative during the close-out. That person alone will be the one who questions any observation unless a person hears a point that is blatantly in error. The head of Quality can, and often does, ask for assistance from other key representatives of the group. Review each item with the auditor. Understand what is being cited. Do not guess or speculate - your response could be far off-target when you speculate or assume. If errors are present, comment on them. Ask for clarification. Auditors are human and can make mistakes. If you have already made corrections - decide whether you will indicate that fact during the closeout. If the points are minor or easily rectified, you could make the comment that actions have already been implemented to correct the problem, but be cautious with this approach. There is a concern that should be noted on this point - If the firm has a knee-jerk reaction and implements corrective actions too quickly, the auditor may be concerned that you are reacting without truly evaluating the systemic nature of the observation. Many questions can be raised, such as: - How did you get the change control implemented so quickly, Have you trained personnel, Did you evaluate all the systems? Your quick response may elicit far worse comments such as: That is not what I meant by the observation. If there are true points of contention, discuss them, but do not argue directly with the auditor. You should not argue every point or even a large percentage of them. It should be understood that these observations are simply points made during an inspection by an auditor. The firm has an ample amount of time to respond to the issues in a written format, citing examples of compliance, references, guides, testimony, etc. Be cautious in committing to anything during the close-out. The auditor is taking notes and will indicate that the firm committed to a particular action or timeframe. This is particularly important during a governmental audit and may result in further actions. There are other means of gaining an understanding of 34 Special Edition: Conducting Audits

3 the observations, including, but not limited to, obtaining the Establishment Inspection Report (EIR) or directly contacting the inspector for questions. Re-establishing Credibility - The Response Once observations are given, particularly on critical or major points, the firm has a limited amount of time to respond. This could range anywhere from 15 to 30 days. If not, a timeframe for response is provided by the auditor. The firm should have a policy in place and adhere to it diligently. This is the firm s chance to re-establish credibility with the auditing body, client, potential client, MHRA, etc. The last thing an auditor or auditing body wants to do is chase down a firm for corrective actions or to conduct extensive follow-up. Any issues with the response, such as, lack of clarity or detail, will only result in a request for further information, followed by more details, followed by another review, etc. This loss of time in obtaining a conclusion to the audit can result in delays in obtaining contracts or governmental approvals. An approach for formulating a response on each observation is recommended as follows: Evaluate the current state of compliance in light of the audit observation. If possible, indicate what is compliant. Identify the root cause of the issue as appropriate. Understand how the firm will resolve the issue systemically. Definitions Quality should be built into the process and auditing alone cannot be relied upon to ensure quality. Actions taken before, during, and after an audit will ultimately determine the level of compliance. Before proceeding further, it is best to define some of the main points being discussed. Without a basis of understanding for these points, misunderstandings and confusion are bound to happen. Audit Compliance Conformance Observation Quality Audit Systemic Audit Planned, independent, and documented assessments to determine whether agreed upon requirements are met. Affirmative indication or judgment that the supplier of a product or service has met requirements. An affirmative indication or judgment that a product or service has met the requirements of the specifications or regulations. An item of objective evidence found during an audit. A systemic and independent examination and evaluation to determine whether quality activities and results comply with planned arrangements and whether these arrangements are implemented effectively and are suitable to achieve objectives. Note: This last section of underlined text is very important to understanding whether one is to respond systemically to an audit finding. The auditor is looking for current implementation of programs AND how you plan to implement corrective actions to observations. A means of conducting an audit that evaluates the systems implemented by a firm to control their operations. Although the auditor or firm may divide their systems into various classifications, a good standard is provided by the U.S. Food and Drug Administration (FDA). (See Attachment I.) Special Edition: Conducting Audits 35

4 Review prior commitments. Are any issues a repeat observation or a repeat observation for the same type system issue? This is critical to know and understand. If you have made a commitment in the past regarding an observation, but the corrective actions were not implemented or did not resolve the issue, the inspecting body will evaluate the current observations in a more critical light. Repeat observations also greatly increase the likelihood of further regulatory actions. Identify the root cause. This is a fundamental principle in the FDA s view of systemic audits and is certainly used widely in Europe as a format for inspections. Figure 2 Responding to an Audit Analyze Observations Determine the Timeline Relate each observation to the appropriate Quality System. Understand the area of impact of the issue in relation to the functions impacted by that system. Develop a corrective action plan around the entire scope of the issue(s) noted. Secure the required resources needed to complete the job in the timeframe indicated. DO NOT underestimate the forces needed to complete a job within schedule - let alone evaluating the outcome of the work. Verify that responsibilities are assigned to key people and make them accountable. Assignments given to departments or groups of people are almost doomed to failure. Someone must be in charge to assign work and to track and modify the assignment as needed. Just as importantly, a single key individual, typically the head of Quality, should be responsible for the overall work. Note: In the steps provided, points one through seven are directly related to formulating a response to the observation. It is critical to understand that points six and seven directly relate to the response letter in that these actions determine the timeframe in which actions can be accomplished. Without knowledge of the requirements needed to complete the actions, the events following the response will fall into one of three categories: 1. Actions needed to finish the task will be completed significantly earlier than the date indicated in the response. The risk here is that the reader of the response will know that it does not take that long and will consider your reaction inappropriate. Review and Re-write Write the Response Letter 2. Actions needed to complete the task are performed prior to the date indicated in the response. This position can be great if planned out and performed in a compliant manner. As some have discovered, much to their chagrin, some response timeframes are not that well thought out and in order to complete the task necessary, monumental actions have to be taken. This may include significant overtime, hiring temporary staff, not completing routine activities, or completing the task with shortcuts or in a non-compliant manner. 3. Actions needed to complete the task are performed after the date indicated in the response. Most audit bodies (even governmental auditors) understand that things happen and sometimes tasks cannot be completed in the time indicated. The audit body 36 Special Edition: Conducting Audits

5 should be notified immediately (the best time for notification is BEFORE the due date of the action). Explain the situation, what has happened, the tasks completed, and the new due date. That being said if missed commitments are frequent enough or happen not once, but two or three times, the auditing body may become concerned and inquire into the situation further. An overview of the process for responding to the audit is provided in Figure 2 and subsequent actions are provided in Figure 3. WRITING THE RESPONSE There are some basic rules that can be established regarding writing a response letter. Some or all of these rules may apply depending upon the particular situation of the firm, e.g.: lengthy list of observations from a governmental body, client audit, warning letter pending, etc. Someone at a high level in the Quality Department should write the response. Personnel copied on the response should include high-level management. This shows that management at the firm is aware of the issues and the commitments being made. Include a cover letter or opening statement. Thank the auditor(s) for being professional, providing insight, or other appropriate remarks as warranted. State the site address of the audit and the dates. Always remember that you are writing the response to the auditors, management, governmental auditing bodies, as well as clients. Do not assume that the person reading the report understands the context of the observation or your reply. Restate the observation and reference number in the response. Typically, the observation goes directly above the response. If possible, indicate the related compliant systems. This shows that you are in control and that some operations were functioning within acceptable Good Manufacturing Practice (GMP) parameters. If the action item is going to take some time to implement, state what will be done in the interim to be compliant with GMPs. Do not merely indicate that actions will be taken in six months to correct the issue in which you are currently out of compliance without addressing what you will do to become compliant from the current date until the corrections are implemented. If corrective actions have already taken place, indicate the following: Dates implemented Training performed (copies of training sign-up sheets included) Copies of purchase orders, installation work, etc. Copies of updated Standard Operating Procedures (SOPs) - indicating what was changed. Define how enhancements will prevent recurrence of the issue observed. Do not assume that the reader will understand this fact. Explain what will be done to expand, enhance, or streamline the compliance system. Do not forget about training. Allow sufficient time to implement changes to incorporate training that may include proficiency testing. Describe how the firm will monitor the progress and effectiveness of the corrective actions. It may be helpful to explain, if apropos, that despite the issue stated, there has never been a problem caused by this issue. It is not advisable to use this response tactic each time, but it can be advantageous for critical observations to state something on the order of the product has always met predetermined quality parameters Revise, revise, and revise again. Allow other people not directly involved with the audit to review and comment on the response. They may have insight on response wording that would assist in clarification or strengthening of points. When initially formulating a response, a four-stage inspection approach may be helpful to develop perspective on the format of the response and contribute to a better understanding of what actually needs to be implemented to attain compliance. Special Edition: Conducting Audits 37

6 Figure 3 Acting on Audit Observations Observations are received at this point Audit Systemic Verification Systemic Analysis Systemic Execution of the Plan Systemic Implementation Plan Response to the audit observations is made at this point This approach includes: 1. Restating the Observation 2. Defining the Root Cause 3. Indicating a Corrective Action 4. Developing a Due Date If this approach is followed completely, any corrective actions will be systemic and should address the root cause(s) defined. This will also aid in the development of due dates because the firm will be more informed as to what actually needs to be accomplished. Response Strategies to Avoid Although the following information is not exhaustive, these are some strategies taken by firms which indicate a firm s unwillingness to change or its inability to make appropriate corrective actions. If a firm does not have the capability, time, or experience to respond appropriately to an audit, especially to a government audit, a prime objective should be to seek outside assistance. Pathways to Disaster Scorched earth. During the closeout or in the response letter, argue every point stating they are not appropriate or we have never had an issue with this point from other auditors. This is called a scorched earth policy and will ensure that the auditor has a strong message of noncompliance to take to the auditing body about your firm. Scare tactic. State that the corrective actions being requested will put the firm out of business or drive jobs to a foreign country. These are scare tactics that have been used for at least 20 years and have not proven to be true. The rain forest or overwhelming response. 38 Special Edition: Conducting Audits

7 Figure 4 Ensuring All Areas Are Corrected Departmental Corrective Actions on a Specific Observation Departmental Corrective Actions on Other Points in Relation to the Specific Observation Site-wide Corrective Actions on a Specific Observation Site-wide Corrective Actions on Other Points in Relation to the Specific Observation Contract Firms, Third Parties, Vendors Site-wide Corrective Actions on Other Points in Relation to the Specific Observation Corporate-wide Evaluation Special Edition: Conducting Audits 39

8 Include massive amounts of data that is not warranted with the hope that the reviewer will be impressed with the work. This type of response sends an immediate warning signal to the auditor that issues are being glossed over. Implement changes immediately. Either during the closeout meeting or with a quick response, all changes have been implemented for complex issues. If the issue is simple, implementing changes quickly is not a problem. However, for complex observations, a rapid response indicates that the firm has taken a knee-jerk reaction and implemented corrective actions without thinking of the root cause. Failure to respond Actions may be taken, but no formal letter is sent indicating what was performed. This approach indicates that the firm does not take the audit seriously. The enigmatic response. The firm indicates that actions are going to be taken but does not address what these actions include. Such an example would include: Actions Taken - Records were updated. When? How were they updated? Promise without substance. Similar to the enigmatic response, this approach does not indicate any specifics. An example includes: Deficiency - Detailed investigation not performed in a timely manner. Response - Investigations will be carried out in a timely manner. MANAGEMENT S ROLE The role of management cannot be understated in its stance regarding a successful audit outcome. The auditor must get the impression that management is informed of issues and is vested in resolving those issues. Some of management roles include: Hosting the inspection. Up front, this will be the first impression that an auditor receives of how the firm actually operates. If no one from management is available or even attempts to participate in the audit, there is a lost opportunity to indicate that the firm is willing to listen and learn from the experience of the auditor. Management does not have to be present during the entire audit, but should be there during the opening and to discuss any key observations. Participation in Closing. Taking part in the closing meeting will indicate that the firm s management is accountable for decisions made and actions taken. Awareness. Management should be aware of or participate in the response letter. Indication of the copy circulation of the response letter should be included on the letter. Commitment. The most critical role of management after the audit is the commitment of resources to accomplish the task in the allotted timeframe. This could range from more money to more people. Beyond the Context of the Direct Observations A systemic response to any audit observations must equate to a systemic resolution to any issues within the firm. This response requires further evaluation than simple actions within a system at a company site. The FDA in particular will require that all company sites implement corrective actions along the same plan of action. Failure to do so may result in further regulatory actions. Programs must be established which require any observations and their responses to be circulated for evaluation within a company to determine whether other areas are noncompliant. Figure 4 illustrates this approach. Helpful Hint #1: EIR Evaluation The FDA will write an Establishment Inspection Report (EIR) on the audit. This report, along with any observations and the firm s response, are submitted to FDA Management for final inspection, conclusions, and closeout (or further action from the District). It is highly recommended that the EIR be obtained by the audited firm and be evaluated for accuracy. Any discrepancies should be diplomatically handled via a letter to the auditor. Helpful Hint #2: Prepare to be Re-inspected After the audit, there is a tenancy to drift back into an operational mode. Along with other daily issues, some commitments may be dropped or forgotten. It is Quality Assurance s (QA) role to ensure that the firm has met their commitments in anticipation of a re-inspection. During the re-inspection, auditors will verify actions taken and timeline adherence. QA should substantiate GMP compliance by assuring the resolutions encompassed root causes were systemic or comprehensive and actually worked to resolve all issues. 40 Special Edition: Conducting Audits

9 CONCLUSION Although comprehensive and seemingly overwhelming, the audit response can be accomplished successfully. This report offers numerous points and options for success when facing an audit. The firm should consider these options when addressing all audit observations and systemically concentrate on any actions. If completed, the firm and auditor are both in a win-win scenario whereby the firm resolves root cause problems and the auditor has fewer repeat observations. ABOUT THE AUTHOR Troy Fugate, Vice President for Compliance Insight, Inc, located near Cincinnati, OH, is a worldwide compliance consultant in the areas of pharmaceutical quality, operations and packaging, laboratory and construction activities. Troy has worked around the globe on a variety of projects and specializes in quality systems, audits, investigations, FDA issue resolution, and training. Troy can be reached at troy@compliance-insight.com. REFERENCES 1. U.S. FDA, Guidance for Industry, Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations, Draft Guidance, September Preparing for Audit and The Quality Audit, Compliance Printing Operational Booklets, 2004 and EIR FDA GMP MHRA QA SOP Article Acronym Listing Establishment Inspection Report Food and Drug Administration Good Manufacturing Practice Medicines and Healthcare Products Regulatory Agency (UK) Quality Assurance Standard Operating Procedure Special Edition: Conducting Audits 41

10 Attachment I FDA Systemic Approach PRODUCTION Maintain Validation Controls Product System FACILITY/ EQUIPMENT Maintain Qualify Controls Calibrate Clean Packaging & Labeling System Quality System Facilities & Eq;uipment Systems PACKAGING/ LABELLING Control Maintain Qualify MATERIAL Control Qualify Materials System Laboratory Controls System LABORATORY Control Disposition Authority Qualify Maintain Calibrate QUALITY Control Disposition Authority Investigate (CAPA) Originally published in the July 2006 issue of The Journal of GXP 42 Special Edition: Conducting Audits

Approaching the Response to Audit Observations

Approaching the Response to Audit Observations Introduction Approaching the Response to Audit Observations One of the first things consistently drilled into my collective memory was the statement that we should always be prepared for an audit. It was

More information

There is no Silver Bullet to complying with the US FDA GMPs by Alan Schwartz

There is no Silver Bullet to complying with the US FDA GMPs by Alan Schwartz There is no Silver Bullet to complying with the US FDA GMPs by Alan Schwartz Recently, we participated in a seminar on United States (US) Food and Drug Administration (FDA) regulations to the Hebei Pharmaceutical

More information

Preparing for Unannounced Inspections from Notified Bodies

Preparing for Unannounced Inspections from Notified Bodies Preparing for Unannounced Inspections from Notified Bodies Europe has introduced further measures for unannounced audits of manufacturers by notified bodies. With this in mind, James Pink, VP Europe-Health

More information

Edwin Lindsay Principal Consultant. Compliance Solutions (Life Sciences) Ltd, Tel: + 44 (0) 7917134922 E-Mail: elindsay@blueyonder.co.

Edwin Lindsay Principal Consultant. Compliance Solutions (Life Sciences) Ltd, Tel: + 44 (0) 7917134922 E-Mail: elindsay@blueyonder.co. Edwin Lindsay Principal Consultant, Tel: + 44 (0) 7917134922 E-Mail: elindsay@blueyonder.co.uk Corrective and Preventative Action (CAPA) is a system of quality procedures required to eliminate the causes

More information

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management

More information

1 www.imarcresearch.com

1 www.imarcresearch.com Risk Management in Clinical Research: PROCESS DEVELOPMENT & APPLICATION Introduction Recently, two key pieces of guidance were released from Food and Drug Administration (FDA) and European Medicines Agency

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

PHARMACEUTICAL TRAINING GUIDELINE

PHARMACEUTICAL TRAINING GUIDELINE PHARMACEUTICAL TRAINING GUIDELINE 5850 Boymel Dr. Suite 1 Fairfield, OH 45014 Tel.: 513.860.3512 Fax: 513.860.3406 www.compliance-insight.com Reorder Item No. 20.020.2 PHARMACEUTICAL TRAINING GUIDELINE

More information

Empowering the Quality and Regulatory Compliance Functions

Empowering the Quality and Regulatory Compliance Functions Empowering the Quality and Regulatory Compliance Functions Management must take steps to ensure that regulatory and quality compliance is everyone s responsibility. By: J. Glenn George, Kenneth Imler,

More information

FDA Inspection Observations The FDA 483 and Beyond. Objectives

FDA Inspection Observations The FDA 483 and Beyond. Objectives FDA Inspection Observations The FDA 483 and Beyond Presenter: David L. Chesney Vice President and Practice Lead PAREXEL Consulting, Waltham, MA Dave.chesney@parexel.com Objectives Describe history and

More information

LabGuide 71. Incident Management: Developing a Plan

LabGuide 71. Incident Management: Developing a Plan LabGuide 71 Incident Management: Developing a Plan INTRODUCTION In light of the Institute of Medicine studies focusing on reducing medical errors, COLA developed Accreditation criterion QA 20 to focus

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director

More information

Company Quality Manual Document No. QM Rev 0. 0 John Rickey Initial Release. Controlled Copy Stamp. authorized signature

Company Quality Manual Document No. QM Rev 0. 0 John Rickey Initial Release. Controlled Copy Stamp. authorized signature Far West Technology, Inc. ISO 9001 Quality Manual Document No.: QM Revision: 0 Issue Date: 27 August 1997 Approval Signatures President/CEO Executive Vice President Vice President/CFO Change Record Rev

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

Making SOP Training More Effective

Making SOP Training More Effective By David Peterson, Director, GMP and Quality Systems, UL EduNeering SOPs are critical to efficient operations, quality control and regulatory compliance. This paper reviews best practices for the Life

More information

TRANSPORT FOR LONDON (TfL) LOW EMISSIONS CERTIFICATE (LEC) GUIDANCE NOTES FOR THE COMPANY AUDIT PROCESS. LEC (Company Audit) Guidance Notes

TRANSPORT FOR LONDON (TfL) LOW EMISSIONS CERTIFICATE (LEC) GUIDANCE NOTES FOR THE COMPANY AUDIT PROCESS. LEC (Company Audit) Guidance Notes TRANSPORT FOR LONDON (TfL) LOW EMISSIONS CERTIFICATE (LEC) GUIDANCE NOTES FOR THE COMPANY AUDIT PROCESS LEC (Company Audit) Guidance Notes Glossary of Terms Transport for London (TfL) London Low Emission

More information

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process

More information

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.

Quality Thinking in other Industries. Dominic Parry Inspired Pharma Training. WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog. Quality Thinking in other Industries Dominic Parry Inspired Pharma Training WEB www.inspiredpharma.com GMP BLOG inspiredpharmablog.com Welcome The traditional focus on quality Quality in the eyes of GMP

More information

ISO/IEC 17025 QUALITY MANUAL

ISO/IEC 17025 QUALITY MANUAL 1800 NW 169 th Pl, Beaverton, OR 97006 Revision F Date: 9/18/06 PAGE 1 OF 18 TABLE OF CONTENTS Quality Manual Section Applicable ISO/IEC 17025:2005 clause(s) Page Quality Policy 4.2.2 3 Introduction 4

More information

ICH guideline Q10 on pharmaceutical quality system

ICH guideline Q10 on pharmaceutical quality system September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final

More information

White paper. Corrective action: The closed-loop system

White paper. Corrective action: The closed-loop system White paper Corrective action: The closed-loop system Contents Summary How corrective action works The steps 1 - Identify non-conformities - Opening a corrective action 6 - Responding to a corrective action

More information

Auditing as a Component of a Pharmaceutical Quality System

Auditing as a Component of a Pharmaceutical Quality System Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a

More information

Property Room. Records Management System

Property Room. Records Management System Property Room Records Management System Louisville Metro Police Department Property Room Records Management System Table of Contents Transmittal Letter... 2 Introduction... 2 Scope... 3 Opinion... 3 Corrective

More information

Incident Management: Developing a Plan

Incident Management: Developing a Plan LABFACTS 71 Incident Management: Developing a Plan INTRODUCTION In light of the Institute of Medicine studies focusing on reducing medical errors, COLA criterion #285 has been changed effective May 1,

More information

PHARMACEUTICAL QUALITY SYSTEM Q10

PHARMACEUTICAL QUALITY SYSTEM Q10 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step

More information

New York City Department of Buildings

New York City Department of Buildings O f f i c e o f t h e N e w Y o r k S t a t e C o m p t r o l l e r Division of State Government Accountability New York City Department of Buildings Outstanding Violations Report 2010-N-5 Thomas P. DiNapoli

More information

Quality Manual. DuraTech Industries, Inc. 3216 Commerce Street La Crosse, WI 54603 MANUAL SERIAL NUMBER 1

Quality Manual. DuraTech Industries, Inc. 3216 Commerce Street La Crosse, WI 54603 MANUAL SERIAL NUMBER 1 Quality Manual Approval Page Document: QA1000 Issue Date: 5/29/1997 Page 1 of 17 Revision Date: 5/20/2013 DuraTech Industries, Inc. 3216 Commerce Street La Crosse, WI 54603 MANUAL SERIAL NUMBER 1 This

More information

Guidance for Industry. Q10 Pharmaceutical Quality System

Guidance for Industry. Q10 Pharmaceutical Quality System Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

FDA BEGINS INSPECTING CONVENIENCE STORES. Agency Seeking to Ensure Compliance with Tobacco Regulations

FDA BEGINS INSPECTING CONVENIENCE STORES. Agency Seeking to Ensure Compliance with Tobacco Regulations Background FDA BEGINS INSPECTING CONVENIENCE STORES Agency Seeking to Ensure Compliance with Tobacco Regulations Although President Obama signed the Family Smoking Prevention and Tobacco Control Act almost

More information

Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy

Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting

More information

GxP Process Management Software. White Paper: Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations

GxP Process Management Software. White Paper: Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations GxP Process Management Software : Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations Most FDA violations involve one of the following: Not having procedures in a regulated area

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP U.S. Department of Health and Human Services Food and Drug Administration Center for Drug

More information

ORACLE CONSULTING GROUP

ORACLE CONSULTING GROUP ORACLE CONSULTING GROUP An Official United States Agent Firm for Foreign Establishments CONSULTING MEMORANDUM: DEALING WITH A MEDICAL DEVICE IN THE U.S. 5398 Golder Ranch Rd., Ste. 1 Tucson, Arizona 85739

More information

GC GUIDANCE ON INHERENTLY GOVERNMENTAL FUNCTIONS

GC GUIDANCE ON INHERENTLY GOVERNMENTAL FUNCTIONS GC GUIDANCE ON INHERENTLY GOVERNMENTAL FUNCTIONS Federal law prohibits contractors from performing inherently governmental functions. But determining which functions may be performed by contractors and

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

ORACLE CONSULTING GROUP

ORACLE CONSULTING GROUP ORACLE CONSULTING GROUP 9 Golder Ranch Rd., Ste. 1 Tucson, Arizona 9 Web Site: E-mail: 20-2-0 20-2-0 (FAX) CONSULTING MEMORANDUM QUALITY SYSTEM INSPECTION TECHNIQUE

More information

The Application and Inspection Process What to Expect

The Application and Inspection Process What to Expect 82 GUIDANCE ON WHOLESALE DISTRIBUTION PRACTICE AND BROKERING Qualification of Customers and Suppliers 112 Qualification of suppliers 113 Compliance with GDP 113 Routine re-qualification 114 Due diligence

More information

Module 17: EMS Audits

Module 17: EMS Audits Module 17: EMS Audits Guidance...17-2 Figure 17-1: Linkages Among EMS Audits, Corrective Action and Management Reviews...17-5 Tools and Forms...17-7 Tool 17-1: EMS Auditing Worksheet...17-7 Tool 17-2:

More information

Schweppes Australia Head Office Level 5, 111 Cecil Street South Melbourne Victoria 3205. www.schweppesaustralia.com.au

Schweppes Australia Head Office Level 5, 111 Cecil Street South Melbourne Victoria 3205. www.schweppesaustralia.com.au Schweppes Australia Head Office Level 5, 111 Cecil Street South Melbourne Victoria 3205 www.schweppesaustralia.com.au Quality Management Systems 1. Quality Management Systems develop, implement, verify

More information

Camber Quality Assurance (QA) Approach

Camber Quality Assurance (QA) Approach Camber Quality Assurance (QA) Approach Camber s QA approach brings a tested, systematic methodology, ensuring that our customers receive the highest quality products and services, delivered via efficient

More information

White paper: FDA Guidance for Industry Update Process Validation

White paper: FDA Guidance for Industry Update Process Validation White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,

More information

City of Raleigh Public Utilities Department. Wastewater EMS Manual

City of Raleigh Public Utilities Department. Wastewater EMS Manual City of Raleigh Public Utilities Department Wastewater EMS Manual TABLE OF CONTENTS PAGE 2 Wastewater EMS Manual Table of Contents Management Direction 1) EMS Manual 2) Management Policy Planning 3) Process

More information

Code of Business Conduct and Ethics. With Special Message for Senior Business and Finance Leaders

Code of Business Conduct and Ethics. With Special Message for Senior Business and Finance Leaders Code of Business Conduct and Ethics With Special Message for Senior Business and Finance Leaders Index Letter from our Chairman & CEO and from our President Annual Letter to Senior Leaders Introduction

More information

Developing Supplier Quality Auditor Training Programs

Developing Supplier Quality Auditor Training Programs Title Slide Place image here in this top corner Size: 2.58 x 2.58 Position: horizontal 0, vertical 0 Developing Supplier Quality Auditor Training Programs Seth A. Mailhot, lead of FDA Regulatory Practice

More information

QUALITY ASSURANCE MANUAL JPM OF MISSISSIPPI, INC.

QUALITY ASSURANCE MANUAL JPM OF MISSISSIPPI, INC. QUALITY ASSURANCE MANUAL JPM OF MISSISSIPPI, INC. Hattiesburg, MS Revision E 01/19/11 Revised to ISO 9001:2008 on July 9, 2009 JPM OF MISSISSIPPI, INC. MANAGEMENT QUALITY POLICY It is the goal of JPM of

More information

Following up recommendations/management actions

Following up recommendations/management actions 09 May 2016 Following up recommendations/management actions Chartered Institute of Internal Auditors At the conclusion of an audit, findings and proposed recommendations are discussed with management and

More information

A WHITE PAPER. SELECTING AN ASEPTIC FILL/FINISH CONTRACT MANUFACTURER: Avoiding the Most Common Mistakes. By John Dobiecki

A WHITE PAPER. SELECTING AN ASEPTIC FILL/FINISH CONTRACT MANUFACTURER: Avoiding the Most Common Mistakes. By John Dobiecki A WHITE PAPER SELECTING AN ASEPTIC FILL/FINISH CONTRACT MANUFACTURER: Avoiding the Most Common Mistakes By John Dobiecki A WHITE PAPER SELECTING AN ASEPTIC FILL/FINISH CONTRACT MANUFACTURER: Avoiding the

More information

Software Validation in Clinical Trial Reporting: Experiences from the Biostatistical & Data Sciences Department

Software Validation in Clinical Trial Reporting: Experiences from the Biostatistical & Data Sciences Department Software Validation in Clinical Trial Reporting: Experiences from the Biostatistical & Data Sciences Department Andrea Baker Senior Programmer GlaxoSmithKline SeUGI 19 Florence May 29-June 1 2001 Introduction

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control

More information

Health Canada s GCP Compliance Program Part 2. GCP Information Sessions November 2010

Health Canada s GCP Compliance Program Part 2. GCP Information Sessions November 2010 Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program Part 2 GCP Information Sessions November 2010 Inspection Program Main objectives

More information

QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT

QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT Heather Longden Senior Marketing Manager Waters Corporation Boston Chapter Educational Meeting June 2016 About Waters Lab Informatics Separations

More information

Quality Management System

Quality Management System Chapter j 38 Self Assessment 739 Quality Management System 1. Is your system thought of as a set of documents or a set of interacting processes that deliver the organization s objectives? 2. Is your system

More information

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Bury DCA United Response, City View Business Centre, 9 Long

More information

Improved Business Process Through XBRL: A Use Case for Business Reporting

Improved Business Process Through XBRL: A Use Case for Business Reporting Improved Business Process Through : A Use Case for Business Reporting CONTENTS PAGE FOREWORD. 3 THE PROBLEM: SIGNIFICANT REPORTING AND BUSINESS PROCESS CHALLENGES FACING BANKING REGULATORS... 4 THE RESULTS:

More information

Compliance Focused Preapproval Preparation Program. By Mike Ronningen, RAC

Compliance Focused Preapproval Preparation Program. By Mike Ronningen, RAC Compliance Focused Preapproval Preparation Program By Mike Ronningen, RAC 14 July 2011 Submitting a Premarket Approval Application (PMA) for a Class III medical device to the US Food and Drug Administration

More information

This unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an

This unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an Music No audio Please review information shown to understand the general course navigation and available resources. Resources, such as the audio script, example forms, and website links, can be accessed

More information

YOUR RIGHTS AS A SECTION 8 TENANT:

YOUR RIGHTS AS A SECTION 8 TENANT: YOUR RIGHTS AS A SECTION 8 TENANT: PROJECT-BASED AND VOUCHERS Copyright April 2012, Legal Aid Society of Hawai i All rights reserved. These materials may not be reproduced without the written permission

More information

POLICY SUBJECT: EFFECTIVE DATE: 5/31/2013. To be reviewed at least annually by the Ethics & Compliance Committee COMPLIANCE PLAN OVERVIEW

POLICY SUBJECT: EFFECTIVE DATE: 5/31/2013. To be reviewed at least annually by the Ethics & Compliance Committee COMPLIANCE PLAN OVERVIEW Compliance Policy Number 1 POLICY SUBJECT: EFFECTIVE DATE: 5/31/2013 Compliance Plan To be reviewed at least annually by the Ethics & Compliance Committee COMPLIANCE PLAN OVERVIEW Sound Inpatient Physicians,

More information

Quality Management System General

Quality Management System General Audit Date: Quality Management System General Requirement: 4.1 and 4.2.2-QMS General Verify Scope Comments/Evidence/Findings: Verify the Exclusions is applicable and justified How are the processes in

More information

John Keel, CPA State Auditor. An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy. August 2015 Report No.

John Keel, CPA State Auditor. An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy. August 2015 Report No. John Keel, CPA State Auditor An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy Report No. 15-039 An Audit Report on Inspections of Compounding Pharmacies at the Board of

More information

Copies of this document shall be classified either as Controlled or Uncontrolled, and shall be identified as such on the cover sheet.

Copies of this document shall be classified either as Controlled or Uncontrolled, and shall be identified as such on the cover sheet. INTRODUCTION This document describes an inspection system broken down into four separate levels. When Inspection Level IV is invoked, this system meets the requirements of former MIL-I-45208A. The primary

More information

DEC STD 017-2 - ISO 9002 - Quality Systems - Model for Quality Assurance in Production and Installation

DEC STD 017-2 - ISO 9002 - Quality Systems - Model for Quality Assurance in Production and Installation Digital Internal Use Only DEC STD 017-2 - ISO 9002 - Quality Systems - Model for Quality Assurance in Production and Installation DOCUMENT IDENTIFIER: A-DS-EL00017-02-0000 Rev A, ABSTRACT: This standard

More information

EMS Example Example EMS Audit Procedure

EMS Example Example EMS Audit Procedure EMS Example Example EMS Audit Procedure EMS Audit Procedures must be developed and documented with goals which: Ensure that the procedures incorporated into the EMS are being followed; Determine if the

More information

UNCONTROLLED COPY FOR REFERENCE ONLY

UNCONTROLLED COPY FOR REFERENCE ONLY CLOVER MACHINE AND MFG. 800 MATHEW ST. #101 SANTA CLARA, CA 95050 727-3380 727-7015 fax REVISION: DATE: PAGE 1 OF 45 QUALITY POLICY MANUAL DISTRIBUTION LIST: President Purchasing Manager Vice President

More information

Steps to ISO/IEC 17025 Accreditation

Steps to ISO/IEC 17025 Accreditation Steps to ISO/IEC 17025 Accreditation Perry Johnson Laboratory Accreditation, Inc. 755 W. Big Beaver Rd., Suite 1325 Troy, MI 48084 U.S.A. Phone: 1-877-369-LABS (248) 519-2603 Fax: 248-213-0737 www.pjlabs.com

More information

4.4 Commissioning, Handover and Warranty

4.4 Commissioning, Handover and Warranty 4.4 Commissioning, Handover and Warranty 4.4.1 Building Commissioning and Manuals The Building Commissioning formalizes the review and integration of all project expectations during the planning and design,

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software

More information

SUPPLIER QUALITY MANAGEMENT SYSTEM QUESTIONNAIRE

SUPPLIER QUALITY MANAGEMENT SYSTEM QUESTIONNAIRE Company Name Street Address City, State, Zip code Phone Number Fax Company Website Email Address ORGANIZATION NAME PHONE NUMBER EMAIL ADDRESS President/CEO General Manager Engineering Manager Production

More information

ISRE 2400 (Revised), Engagements to Review Historical Financial Statements

ISRE 2400 (Revised), Engagements to Review Historical Financial Statements International Auditing and Assurance Standards Board Exposure Draft January 2011 Comments requested by May 20, 2011 Proposed International Standard on Review Engagements ISRE 2400 (Revised), Engagements

More information

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Harrow Health Limited 37 Love Lane, Pinner, Harrow, HA5 3EE

More information

May 2016. Duke Energy EHSMS Manual. Environmental, Health and Safety Management System Manual

May 2016. Duke Energy EHSMS Manual. Environmental, Health and Safety Management System Manual Environmental, Health and Safety Management System Manual 1 Table of Contents I INTRODUCTION... 3 II ENVIRONMENTAL POLICY... 5 III HEALTH AND SAFETY POLICY... 6 IV EHS MANAGEMENT ROLES AND IV RESPONSIBILITIES...

More information

Audit of the Trusted Traders Programs

Audit of the Trusted Traders Programs Audit of the Trusted Traders Programs July 2013 TABLE OF CONTENTS 1.0 INTRODUCTION... 2 2.0 SIGNIFICANCE OF THE AUDIT... 2 3.0 STATEMENT OF CONFORMANCE... 3 4.0 AUDIT OPINION... 3 5.0 KEY FINDINGS... 3

More information

FDA Guidance for Industry Update - Process Validation

FDA Guidance for Industry Update - Process Validation FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead

More information

SUPPLIER QUALITY SYSTEM AUDIT

SUPPLIER QUALITY SYSTEM AUDIT Company Name: Date: Company Address: Quality Assurance Mgr: President: Number of employees: Is your company receptive to source inspection? List all standards the quality system is based on Web Page: Company

More information

Optimizing Regulatory Compliance: Nine Strategies for Success

Optimizing Regulatory Compliance: Nine Strategies for Success Optimizing Regulatory Compliance: Nine Strategies for Success Regulatory Outlook Medical device firms need to create an organizational structure around the QSR, and they need to follow the procedures it

More information

PharmAssess Audit Reports Operational Consultancy GMP Auditing Services Regulatory Affairs. www.rephine.com

PharmAssess Audit Reports Operational Consultancy GMP Auditing Services Regulatory Affairs. www.rephine.com PharmAssess Audit Reports Operational Consultancy GMP Auditing Services Regulatory Affairs www.rephine.com The Market Leader in GMP Audit Reporting PharmAssess audit reports are accepted by all Regulatory

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Risk Management Advisory Services, LLC Capital markets audit and control

Risk Management Advisory Services, LLC Capital markets audit and control Risk Management Advisory Services, LLC Capital markets audit and control November 14, 2003 Office of the Secretary Public Company Accounting Oversight Board 1666 K Street, N.W. Washington, D.C., 20006-2803

More information

QUALITY POLICY MANUAL Document: 01-090000 Revision: E Effective Date: January 15, 2010

QUALITY POLICY MANUAL Document: 01-090000 Revision: E Effective Date: January 15, 2010 Section i INTRODUCTION QUALITY POLICY STATEMENT: The purpose of our business is to provide continuity of electrical power to keep businesses in business. We do this by helping clients solve their power

More information

Change Management Communications Plan. March 13, 2003

Change Management Communications Plan. March 13, 2003 March 13, 2003 TABLE OF CONTENTS 1. PURPOSE... 1 2. ISSUE DEFINITION... 1 3. ROOT CAUSE ANALYSIS... 3 4. ACTIONS... 4 A. NEW EDITS FOR EXISTING BUSINESS RULES (ORDER AND PRE-ORDER)... 4 B. MODIFICATIONS

More information

Operations Integrity Management System

Operations Integrity Management System Operations Integrity Management System OPERATIONS INTEGRITY MANAGEMENT SYSTEM: chairman s message 3 ExxonMobil remains steadfast in its commitment to excellence in Safety, Security, Health and Environmental

More information

Corrective and Preventive Action Background & Examples Presented by:

Corrective and Preventive Action Background & Examples Presented by: Corrective and Preventive Action Background & Examples Presented by: Kimberly Lewandowski-Walker Food and Drug Administration Division of Domestic Field Investigations Office of Regulatory Affairs Overview

More information

TRANSITION BEHAVIOR SCALE IEP AND INTERVENTION MANUAL

TRANSITION BEHAVIOR SCALE IEP AND INTERVENTION MANUAL TRANSITION BEHAVIOR SCALE IEP AND INTERVENTION MANUAL Goals, Objectives, and Intervention Strategies for Behavior Necessary for Success in Independent Living and Employment Stephen B. McCarney Copyright

More information

NORTH AMERICA OPERATIONS. (Fairmont and Montreal Facilities) QUALITY MANUAL. Prepared to comply with the requirements of ISO 9001:2008

NORTH AMERICA OPERATIONS. (Fairmont and Montreal Facilities) QUALITY MANUAL. Prepared to comply with the requirements of ISO 9001:2008 WEIGH-TRONIX CANADA ULC NORTH AMERICA OPERATIONS (Fairmont and Montreal Facilities) QUALITY MANUAL Prepared to comply with the requirements of ISO 9001:2008 Meets or exceeds the requirements for design,

More information

NABL NATIONAL ACCREDITATION

NABL NATIONAL ACCREDITATION NABL 160 NABL NATIONAL ACCREDITATION BOARD FOR TESTING AND CALIBRATION LABORATORIES GUIDE for PREPARING A QUALITY MANUAL ISSUE NO. : 05 AMENDMENT NO : 00 ISSUE DATE: 27.06.2012 AMENDMENT DATE: -- Amendment

More information

Specialties Manufacturing. Talladega Castings & Machine Co., Inc. ISO 9001:2008. Quality Manual

Specialties Manufacturing. Talladega Castings & Machine Co., Inc. ISO 9001:2008. Quality Manual Specialties Manufacturing Talladega Castings & Machine Co., Inc. ISO 9001:2008 This document is the property of TMS and may not be reproduced, wholly, or in part, without the express consent of TMS. Rev.

More information

Documenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility

Documenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility Documenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility Kellie Wittman, Tompkins Associates September 2009 www.tompkinsinc.com Contents Introduction 3 Why bother

More information

PERFORMANCE DEVELOPMENT PROGRAM

PERFORMANCE DEVELOPMENT PROGRAM PERFORMANCE DEVELOPMENT PROGRAM Document Number SOP2009-056 File No. 08/470-02 (D009/8429) Date issued 16 September 2009 Author Branch Director Workforce Unit Branch contact Strategic Projects Coordinator

More information

Corporate Compliance and Ethics Program Effective as adopted on February 21, 2012

Corporate Compliance and Ethics Program Effective as adopted on February 21, 2012 Corporate Compliance and Ethics Program Effective as adopted on February 21, 2012 Page 1 of 7 SECTION 1. STATEMENT OF INTENT As a specialty pharmaceutical company and diagnostic laboratory, Prometheus

More information

EXHIBIT MATERIALS MANAGEMENT REQUIREMENTS FOR CONTRACTED STORAGE PROVIDERS

EXHIBIT MATERIALS MANAGEMENT REQUIREMENTS FOR CONTRACTED STORAGE PROVIDERS EXHIBIT MATERIALS MANAGEMENT REQUIREMENTS FOR CONTRACTED STORAGE PROVIDERS TABLE OF CONTENTS 1. General 1.1. Purpose 1.2. Scope 1.3. Target groups and responsibility 1.3.1. Target groups 1.3.2. Roles and

More information

Internal Audit Manual

Internal Audit Manual Internal Audit Manual Version 1.0 AUDIT AND EVALUATION SECTOR AUDIT AND ASSURANCE SERVICES BRANCH INDIAN AND NORTHERN AFFAIRS CANADA April 25, 2008 #933907 Acknowledgements The Institute of Internal Auditors

More information

The EU Clinical Trial Regulation A regulator s perspective

The EU Clinical Trial Regulation A regulator s perspective 5 The EU Clinical Trial A regulator s perspective Author Martyn Ward, Group Manager, Licensing, Medicines and Healthcare products Regulatory Agency (MHRA), UK. Keywords Clinical Trial Directive (the Directive);

More information

How quality assurance reviews can strengthen the strategic value of internal auditing*

How quality assurance reviews can strengthen the strategic value of internal auditing* How quality assurance reviews can strengthen the strategic value of internal auditing* PwC Advisory Internal Audit Table of Contents Situation Pg. 02 In response to an increased focus on effective governance,

More information

How to Survive an FDA Computer Validation Audit

How to Survive an FDA Computer Validation Audit How to Survive an FDA Computer Validation Audit The Myth Within the pharmaceutical, biotech, and medical device industry there is much fear and concern over approaching FDA audits. The FDA strikes fear

More information

Quality Management System Manual ISO9001:2008

Quality Management System Manual ISO9001:2008 Quality Management System Manual ISO9001:2008 Controlled Copy Rev. 3 Page 1 of 21 7/1/13 Table of Contents Company Profile...5 Past...5 Present...5 Mission...5 Vision...5 Locations...6 1 Scope...6 1.1

More information

Using Insight Auditing SWOT Analysis to Drive Business Excellence

Using Insight Auditing SWOT Analysis to Drive Business Excellence Using Insight Auditing SWOT Analysis to Drive Business Excellence For many organizations, the process of auditing their quality management system can seem to be a daunting, time-consuming, and an expensive

More information

The FDA recently announced a significant

The FDA recently announced a significant This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction

More information

Preparation for a Software Quality Audit

Preparation for a Software Quality Audit Quality Report Preparation for a Software Quality Audit June 1996 Software Quality Assurance Subcommittee of the Nuclear Weapons Complex Quality Managers United States Department of Energy Albuquerque

More information